Experts in population health, engineering and medicine will study and address harms related to the manmade pollutants known as PFAS.
In USC-led research, the new drug candidate selectively attacked glioblastoma stem cells and passed early safety testing in a Phase 1 clinical trial.
A breast milk sensor developed by a USC biomedical engineering team detects acetaminophen, other chemicals and nutrients in real time.
USC research finds that obesity, gestational diabetes and hypertensive disorders of pregnancy were tied to elevated blood pressure in offspring, with effects that grow as children age.
A USC-led team found that about twice as many teens used nicotine pouches in 2024 than in 2023.
USC research also found that independent pharmacies and those in low-income, Black or Latino communities were more likely to be excluded from the preferred networks.
Biomedical engineering research at USC has unraveled a mystery of motor control that could be a game-changer for disorders like Parkinson’s and could aid in the development of bio-inspired systems.
The program has graduated more than 300 alumni who have entered medical and doctoral programs and pursued successful careers in academia, industry and beyond.
USC Marshall alumnus Omar Abdullateef launches WellTra.Ai with support from the USC Marshall Greif Incubator and Greif Center’s New Venture Seed Competition.
The hospital is once again recognized by The Leapfrog Group, an independent national nonprofit watchdog focused on patient safety.
